RVL Pharmaceuticals Revenue and Competitors
Estimated Revenue & Valuation
- RVL Pharmaceuticals's estimated annual revenue is currently $165.9M per year.
- RVL Pharmaceuticals's estimated revenue per employee is $9,758,824
- RVL Pharmaceuticals's current valuation is $94.1M. (January 2022)
Employee Data
- RVL Pharmaceuticals has 17 Employees.
- RVL Pharmaceuticals grew their employee count by -23% last year.
RVL Pharmaceuticals's People
| Name | Title | Email/Phone |
|---|---|---|
1 | EVP & Chief Operating Officer | Reveal Email/Phone |
2 | EVP, COO | Reveal Email/Phone |
3 | VP, U.S. Sales | Reveal Email/Phone |
4 | VP, Regulatory Affairs & Quality Assurance | Reveal Email/Phone |
5 | VP Supply Chain & Procurement | Reveal Email/Phone |
6 | VP Program Mgmt & Contracts Officer | Reveal Email/Phone |
7 | SVP, Business Development | Reveal Email/Phone |
8 | Plant Manager, VP | Reveal Email/Phone |
9 | EVP, Human Resources | Reveal Email/Phone |
10 | Sr. Director, Market Development and Medical Marketing | Reveal Email/Phone |
RVL Pharmaceuticals Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $6.6M | 33 | 32% | N/A | N/A |
#2 | $38M | 189 | 6% | N/A | N/A |
#3 | $6.6M | 33 | 22% | N/A | N/A |
#4 | $4180M | 15242 | 1% | $550M | N/A |
#5 | $17.5M | 87 | 50% | N/A | N/A |
#6 | $6.7M | 125 | -37% | $199.6M | N/A |
#7 | $10.9M | 54 | 15% | N/A | N/A |
#8 | $15.3M | 76 | 33% | N/A | N/A |
#9 | $128.6M | 640 | 16% | N/A | N/A |
#10 | $18.7M | 93 | 21% | N/A | N/A |
What Is RVL Pharmaceuticals?
RVL Pharmaceuticals, Inc. is a new operating subsidiary of Osmotica Pharmaceuticals plc (Nasdaq: OSMT), and was created for the purpose of bringing Upneeq® (oxymetazoline hydrochloride ophthalmic solution), 0.1% to market. RVL Pharmaceuticals, Inc. is dedicated to developing unique partnerships with customers, as well as making Upneeq® available exclusively through our fully-owned and integrated pharmacy. Osmotica Pharmaceuticals plc is a fully integrated biopharmaceutical company focused on the development and commercialization of specialty products that target markets with underserved patient populations.
keywords:N/A
N/A
Total Funding
17
Number of Employees
$165.9M
Revenue (est)
-23%
Employee Growth %
$94.1M
Valuation
N/A
Accelerator
RVL Pharmaceuticals News
RVL Pharmaceuticals plc Announces Preliminary First Quarter 2022 UPNEEQ® Net Product Sales Results. April 06, 2022 06:50 ET | Source: RVL Pharmaceuticals...
RVL Pharmaceuticals plc Reports Fourth Quarter and Full Year 2021 Financial Results; Provides Preliminary First Quarter 2022 UPNEEQ® Revenue...
Hapless Osmotica renamed itself RVL Pharmaceuticals. · It has a novel business model which vastly simplifies its business. · Encouragingly, recent...
Other Companies in Bridgewater
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $165.9M | 17 | -23% | N/A |
#2 | $1.5M | 17 | -11% | N/A |
#3 | $1.7M | 19 | -5% | N/A |
#4 | $5M | 20 | 18% | N/A |
#5 | $2M | 20 | -20% | N/A |